Cargando…

Efficacy and safety of octreotide treatment for diazoxide‐unresponsive congenital hyperinsulinism in China

IMPORTANCE: Octreotide is an off‐label medicine for congenital hyperinsulinism (CHI), but is currently widely used for treatment of patients with CHI. Thus far, variable efficacy and adverse effects have been reported for octreotide. OBJECTIVE: The present study evaluated the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Bingyan, Di, Wu, Su, Chang, Chen, Jiajia, Liang, Xuejun, Liu, Min, Li, Wenjing, Li, Xiaoqiao, Gong, Chunxiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331369/ https://www.ncbi.nlm.nih.gov/pubmed/32851339 http://dx.doi.org/10.1002/ped4.12175

Ejemplares similares

Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
por: Hussain, Suhaimi, et al.
Publicado: (2015)

Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism
por: Lee, Cheng-Ting, et al.
Publicado: (2023)

A novel mutation of ABCC8 gene in a patient with diazoxide-unresponsive congenital hyperinsulinism
por: Park, Ji Sook, et al.
Publicado: (2016)

Diazoxide-Unresponsive Congenital Hyperinsulinism in Children With Dominant Mutations of the β-Cell Sulfonylurea Receptor SUR1
por: MacMullen, Courtney M., et al.
Publicado: (2011)

Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11
por: Hewat, Thomas I., et al.
Publicado: (2021)

Novel Compound Heterozygous Variants of the ABCC8 Gene Warrant Identification of Pancreatic Histology in Infant with Diazoxide-unresponsive Congenital Hyperinsulinism
por: Al Balwi, Rana, et al.
Publicado: (2021)

SUN-690 HNF4A Mutation in Siblings with Diazoxide Responsive Congenital Hyperinsulinism
por: Erkin-Cakmak, Ayca, et al.
Publicado: (2020)

Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism
por: Boskabadi, Seyyed Javad, et al.
Publicado: (2023)

Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy
por: Arya, Ved Bhushan, et al.
Publicado: (2014)

SUN-273 Diazoxide Use to Limit Weight Gain and Reduce Appetite in a Normoglycaemic Child with Previous Congenital Hyperinsulinism
por: Ludwig, Karissa, et al.
Publicado: (2019)

Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation
por: Kiff, Sarah, et al.
Publicado: (2019)

PSUN340 Two cases of diffuse form of diazoxide-responsive congenital hyperinsulinism confirmed by 18F-DOPA PET-CT
por: Yu, Jeesuk, et al.
Publicado: (2022)

MON-105 A Case Report of Neonatal Hyperinsulinism in an Infant with Turner Syndrome Successfully Treated with Diazoxide
por: Patterson, Rebecca J, et al.
Publicado: (2020)

Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism
por: Hashemian, Somayyeh, et al.
Publicado: (2020)

Neonatal Hypo-Ketotic Hypoglycemia Secondary to Transient Hyperinsulinism: Diazoxide Responsiveness and Experience With Fasting Test After Treatment Withdrawal
por: Martín, Nerea Itza, et al.
Publicado: (2021)

The critical BMI hypothesis for puberty initiation and the gender prevalence difference: Evidence from an epidemiological survey in Beijing, China
por: Liu, Meijuan, et al.
Publicado: (2022)

Genetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China
por: Cao, Bingyan, et al.
Publicado: (2016)

Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPA(R)
por: Skae, Mars, et al.
Publicado: (2014)

Familial Focal Congenital Hyperinsulinism
por: Ismail, Dunia, et al.
Publicado: (2011)

Global Registries in Congenital Hyperinsulinism
por: Pasquini, Tai L. S., et al.
Publicado: (2022)

Syndromic forms of congenital hyperinsulinism
por: Zenker, Martin, et al.
Publicado: (2023)

Congenital Hyperinsulinism International: A Community Focused on Improving the Lives of People Living With Congenital Hyperinsulinism
por: Raskin, Julie, et al.
Publicado: (2022)

Clinical and genetic characteristics of hypophosphatasia in Chinese children
por: Liu, Meijuan, et al.
Publicado: (2021)

High Prevalence of Obesity but Low Physical Activity in Children Aged 9–11 Years in Beijing
por: Liu, Meijuan, et al.
Publicado: (2021)

Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China
por: Xu, Aijing, et al.
Publicado: (2019)

Sirolimus treatment of severe congenital hyperinsulinism
por: Amato, Lisa A, et al.
Publicado: (2015)

A Case Series: Congenital Hyperinsulinism
por: Alaei, Mohammad Reza, et al.
Publicado: (2016)

Congenital Hyperinsulinism: Diagnosis and Treatment Update
por: Demirbilek, Hüseyin, et al.
Publicado: (2017)

The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism
por: Galcheva, Sonya, et al.
Publicado: (2019)

Clinical practice guidelines for congenital hyperinsulinism
por: Yorifuji, Tohru, et al.
Publicado: (2017)

Clinical features and predictors of remission in children under the age of 7 years with Graves’ disease
por: Gu, Yi, et al.
Publicado: (2020)

An Evaluation of the Accuracy of a Flash Glucose Monitoring System in Children with Diabetes in comparison with Venous Blood Glucose
por: Cao, Bingyan, et al.
Publicado: (2019)

Hormonal changes throughout puberty in boys: an observational study on the treatment outcome of congenital hypogonadotropic hypogonadism
por: Ren, Xiaoya, et al.
Publicado: (2022)

Octreotide Infusion for the Treatment of Congenital Chylothorax
por: Kobeisy, Sumayyah Ahmed Nezar, et al.
Publicado: (2020)

Congenital hyperinsulinism: current trends in diagnosis and therapy
por: Arnoux, Jean-Baptiste, et al.
Publicado: (2011)

Congenital hyperinsulinism: current status and future perspectives
por: Yorifuji, Tohru
Publicado: (2014)

The molecular mechanisms, diagnosis and management of congenital hyperinsulinism
por: Senniappan, Senthil, et al.
Publicado: (2013)

Nifedipine in Congenital Hyperinsulinism- A Case Report
por: Khawash, Papiya, et al.
Publicado: (2015)

Therapies and outcomes of congenital hyperinsulinism‐induced hypoglycaemia
por: Banerjee, I., et al.
Publicado: (2018)

Possible New Strategies for the Treatment of Congenital Hyperinsulinism
por: Sikimic, Jelena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9fkkefi4uulnu5tckem8kl8vj1